^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

EGFR exon 18 mutation

i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor, KRAS, KRAS1, KRAS2, Kirsten rat sarcoma viral oncogene homolog
Entrez ID:
almost3years
Clinical
|
EGFR (Epidermal growth factor receptor) • HER-2 (Human epidermal growth factor receptor 2) • PD-L1 (Programmed death ligand 1) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS)
|
PIK3CA E542K • EGFR exon 18 mutation • PIK3CA E542
3years
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR exon 18 mutation
|
Nerlynx (neratinib)
3years
Pan tumor
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR G719X • EGFR exon 18 mutation
|
Nerlynx (neratinib)
3years
EGFR (Epidermal growth factor receptor) • HER-2 (Human epidermal growth factor receptor 2) • KRAS (KRAS proto-oncogene GTPase)
|
KRAS G12C • HER-2 overexpression • EGFR exon 20 insertion • KRAS G12 • EGFR exon 20 mutation • EGFR exon 18 mutation
|
Nerlynx (neratinib) • Lumakras (sotorasib) • Rybrevant (amivantamab-vmjw) • Exkivity (mobocertinib) • datopotamab deruxtecan (DS-1062a)